A SELECT trial subanalysis showed that semaglutide works as well in people with CVD, overweight/obesity, and impaired kidney ...

Representational Photo The exploration of novel peptides for their potential impact on metabolic pathways has been a ...

MADRID — The benefits of semaglutide treatment in reducing kidney disease, cardiovascular, and mortality risks in people with ...

Among patients receiving persistent medication at one year, 61% of patients prescribed semaglutide for obesity achieved at ...

Semaglutide may be an effective treatment for the skin condition hidradenitis suppurative, common in people with obesity, say ...

Among participants with no history of major psychopathology, there is no association between semaglutide and depression and suicidality.

Grappling with obesity and the metabolic diseases cascading from it, they are now among the plurality of Americans who have ...

Whether positive or negative, your mood may feel different on GLP-1 medications. Researchers share why that might be and how ...

China has started cracking down on unlicensed production and sale of medicines similar to Novo Nordisk A/S’s blockbuster ...

The anti-obesity medication semaglutide may help to prevent heart attacks, strokes, and other major adverse cardiovascular ...

Semaglutide and tirzepatide treatment lead to significant weight loss and improve blood sugar control in individuals with ...